These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2007-001530-14 Essai de Phase III, Multicentrique, Randomisé, comparant la Chimiothérapie d’induction par Docétaxel, Cisplatine et 5-Fluorouracile (TPF) suivie d’une chimio-radiothérapie concomitante versus une chim... not-yet-due
Not reported 2007-002004-18 Essai randomisé multicentrique de phase III, évaluant l’apport d’une chimiothérapie concomitante chez les patients traités par Radiothérapie–Erbitux pour un carcinome localement évolué des VADS 2019-03-26 due-trials
Listed as ongoing, but also has a completion date 2008-004869-25 Étude de phase II évaluant l’association cetuximab, docétaxel et cisplatine en première ligne de traitement des carcinomes épidermoïdes de la tête et du cou métastatiques ou récidivants 2014-06-27 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-005760-14 Etude de phase III randomisée, multicentrique comparant une chimiothérapie d’induction par TPF suivie d’une association radiothérapie Erbitux® versus une radiochimiothérapie concomitante chez des pati... 2018-11-06 bad-data
Reported results 2009-015457-21 Etude de phase II, multicentrique, évaluant l’efficacité et la tolérance d’une association Réirradiation-Erbitux chez des patients précédemment irradiés et présentant une récidive locale inopérable d’... 2016-07-05 due-trials
Listed as ongoing, but also has a completion date and reported results 2014-000048-14 Randomized, controlled trial of Platinum-Cetuximab combined either with Docetaxel (TPEx) or with 5FU (Extreme) in patients with recurrent/metastatic squamous cell cancer of the head and neck Estudi... 2022-12-21 bad-data
Other 2014-005188-34 Phase III trial of laryngeal preservation comparating Induction chemotherapy with cisplatin, 5-fluorouracil and docetaxel (TPF) followed by radiotherapy and concomitant administration of radiotherapy... not-yet-due
Reported results 2015-001928-29 Phase II randomized trial comparating two concomitant administration of radiotherapy with cisplatin in patients with not operated or inoperable squamous cell carcinoma of the head and neck or with re... 2021-05-10 due-trials
Other 2016-001816-39 Phase III randomized trial comparating concomittant administration of radiotherapy with cisplatin versus radiotherapy only for treatment of sinuses tumors and salivary glands Essai de Phase III ran... not-yet-due
Other 2016-004383-19 A Phase III randomized trial of avelumab-cetuximab-Radiotherapy versus standards of care in locally advanced squamous cell carcinoma of the head and neck Essai de phase III randomisé comparant l’as... not-yet-due
Other 2017-004936-13 A phase III randomized trial of post-operative adjuvant nivolumab and concomitant chemo-radiotherapy in high-risk patients with resected squamous cell carcinoma of head and neck (SCCHN) not-yet-due
Other 2018-001976-39 A phase II trial of radiotherapy-durvalumab without prophylactic neck irradiation in squamous cell carcinoma of the head and neck Essai de phase II évaluant l’association radiothérapie-durvalumab ... not-yet-due
Other 2020-000770-21 A phase II randomized trial, non comparative, evaluating chemotherapy associated cisplatin, 5-fluorouracil and docetaxel at adapted doses in patients with locally advanced squamous cell carcinoma E... not-yet-due